These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15946428)

  • 1. Histologic variation of grade and stage of non-alcoholic fatty liver disease in liver biopsies.
    Janiec DJ; Jacobson ER; Freeth A; Spaulding L; Blaszyk H
    Obes Surg; 2005 Apr; 15(4):497-501. PubMed ID: 15946428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass.
    Larson SP; Bowers SP; Palekar NA; Ward JA; Pulcini JP; Harrison SA
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1329-32. PubMed ID: 17702661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of wedge and needle hepatic biopsy in open bariatric surgery.
    Padoin AV; Mottin CC; Moretto M; Berleze D; Kupski C; Glock L; Reichel CL; da Silva VD; da Silva JB
    Obes Surg; 2006 Feb; 16(2):178-82. PubMed ID: 16469220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of non-alcoholic steatohepatitis in morbidly obese subjects undergoing gastric bypass.
    Spaulding L; Trainer T; Janiec D
    Obes Surg; 2003 Jun; 13(3):347-9. PubMed ID: 12841891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection.
    Regev A; Berho M; Jeffers LJ; Milikowski C; Molina EG; Pyrsopoulos NT; Feng ZZ; Reddy KR; Schiff ER
    Am J Gastroenterol; 2002 Oct; 97(10):2614-8. PubMed ID: 12385448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery.
    Barker KB; Palekar NA; Bowers SP; Goldberg JE; Pulcini JP; Harrison SA
    Am J Gastroenterol; 2006 Feb; 101(2):368-73. PubMed ID: 16454845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients.
    Shalhub S; Parsee A; Gallagher SF; Haines KL; Willkomm C; Brantley SG; Pinkas H; Saff-Koche L; Murr MM
    Obes Surg; 2004 Jan; 14(1):54-9. PubMed ID: 14980034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease.
    Clark JM; Alkhuraishi AR; Solga SF; Alli P; Diehl AM; Magnuson TH
    Obes Res; 2005 Jul; 13(7):1180-6. PubMed ID: 16076987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective comparison of vertical banded gastroplasty and Roux-en-Y gastric bypass in a non-superobese population.
    Kalfarentzos F; Skroubis G; Kehagias I; Mead N; Vagenas K
    Obes Surg; 2006 Feb; 16(2):151-8. PubMed ID: 16469216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological changes in the liver of morbidly obese patients: correlation with metabolic parameters.
    Wolf AM; Busch B; Kuhlmann HW; Beisiegel U
    Obes Surg; 2005 Feb; 15(2):228-37. PubMed ID: 15802066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
    Weiner RA
    Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The comparison of scoring scales for liver biopsy assessment in morbidly obese patients undergoing bariatric surgery.
    Ziolkowski A; Wylezol M; Kukla M; Zwirska-Korczala K; Berdowska A; Pardela M; Gabriel A
    Obes Surg; 2005 Oct; 15(9):1309-14. PubMed ID: 16259893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease.
    Merriman RB; Ferrell LD; Patti MG; Weston SR; Pabst MS; Aouizerat BE; Bass NM
    Hepatology; 2006 Oct; 44(4):874-80. PubMed ID: 17006934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proposal for a histological scoring and grading system for non-alcoholic fatty liver disease.
    Mendler MH; Kanel G; Govindarajan S
    Liver Int; 2005 Apr; 25(2):294-304. PubMed ID: 15780053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Totally robotic Roux-en-Y gastric bypass.
    Mohr CJ; Nadzam GS; Curet MJ
    Arch Surg; 2005 Aug; 140(8):779-86. PubMed ID: 16103289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roux-en-Y gastric bypass improves the nonalcoholic steatohepatitis (NASH) of morbid obesity.
    de Almeida SR; Rocha PR; Sanches MD; Leite VH; da Silva RA; Diniz MT; Diniz Mde F; Rocha AL
    Obes Surg; 2006 Mar; 16(3):270-8. PubMed ID: 16545157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years.
    Furuya CK; de Oliveira CP; de Mello ES; Faintuch J; Raskovski A; Matsuda M; Vezozzo DC; Halpern A; Garrido AB; Alves VA; Carrilho FJ
    J Gastroenterol Hepatol; 2007 Apr; 22(4):510-4. PubMed ID: 17376042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic histopathology of patients with morbid obesity submitted to gastric bypass.
    Lima ML; Mourão SC; Diniz MT; Leite VH
    Obes Surg; 2005 May; 15(5):661-9. PubMed ID: 15946458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease.
    Mathurin P; Hollebecque A; Arnalsteen L; Buob D; Leteurtre E; Caiazzo R; Pigeyre M; Verkindt H; Dharancy S; Louvet A; Romon M; Pattou F
    Gastroenterology; 2009 Aug; 137(2):532-40. PubMed ID: 19409898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.